Systemic administration of Zn2+ during the reperfusion phase of transient cerebral ischaemia protects rat hippocampus against iron-catalysed postischaemic injury

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 7, 2008, Pages 775-781

  Helal, Gouda K ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Al Azhar University   (Egypt)

Author keywords

Apoptosis; Iron; Ischaemia reperfusion; Lipid peroxidation; Metallotionein; Zn2+

Indexed keywords

IRON; METALLOTHIONEIN; ZINC; ZINC CHLORIDE; CHLORIDE; ZINC DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CATALYSIS; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PERMEABILITY; RAT; REPERFUSION; SINGLE DRUG DOSE; STROKE; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; PATHOLOGY; REPERFUSION INJURY; TRANSIENT ISCHEMIC ATTACK; WISTAR RAT;

ANIMALS; CATALYSIS; CHLORIDES; HIPPOCAMPUS; IRON; ISCHEMIC ATTACK, TRANSIENT; MALE; RATS; RATS, WISTAR; REPERFUSION INJURY; ZINC; ZINC COMPOUNDS;

EID: 44349107651     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04858.x     Document Type: Article

References (51)

1. Thomas M, Jankovic J. Neurodegenerative disease and iron storage in the brain. Curr. Opin. Neurol. 2004 17 : 437 42.
2. Nita DA, Nita V, Spulber S et al. Oxidative damage following cerebral ischemia depends on reperfusion: A biochemical study in rat. J. Cell Mol. Med. 2001 5 : 163 70.
3. Imaizumi S, Kayama T, Suzuki J. Chemiluminescence in hypoxic brain: The first report. Correlation between energy metabolism and free radical reaction. Stroke 1984 15 : 1061 5.
4. Kumura E, Yoshimine T, Iwatsuki KI et al. Generation of nitric oxide and superoxide during reperfusion after focal cerebral ischemia in rats. Am. J. Physiol. 1996 270 : C748 52.
5. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev. 2001 53 : 135 59.
6. Kontos HA. Oxygen radicals in cerebral ischemia: The 2001 Willis Lecture. Stroke 2001 32 : 2712 16.
7. Yang GY, Betz AL. Injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 1994 25 : 1658 64.
8. Chang Y, Hsiao G, Chen S et al. Tetramethylpyrazine suppresses HIF-1α, TNF-α, and activated caspase-3 expression in middle cerebral artery occlusion-induced brain ischemia in rats. Acta Pharmacol. Sin. 2007 28 : 327 33.
9. Thiyagarajan M, Kaul CL, Sharma SS. Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats. Br. J. Pharmacol. 2004 142 : 899 911.
10. Powell SR. The antioxidant properties of zinc. J. Nutr. 2000 130 : S1447 54.
11. Connor JR, Menzies SL. Cellular management of iron in the brain. J. Neurol. Sci. 1995 134 (Suppl 33 44.
12. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron, and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 1998 158 : 47 52.
13. Smith MA, Harris PL, Sayre LM, Perrt G. Iron accumulation in Alzheimer's disease is a source of redox-generated free radicals. Proc. Natl Acad. Sci. USA 1997 94 : 9866 8.
14. Gassen M, Youdim MB. The potential role of iron chelators in the treatment of Parkinson's disease and related neurological disorders. Pharmacol. Toxicol. 1997 80 : 159 66.
15. Hartley A, Cooper JM, Schapira AHV. Iron induced oxidative stress and mitochondrial dysfunction: Relevance to Parkinson's disease. Brain Res. 1993 627 : 349 53.
16. Hirsch EC, Faucheux BA. Iron metabolism and Parkinson's disease. Mov. Disord. 1998 13 (Suppl. 1 39 45.
17. Lipscomb DC, Gorman LG, Traystman R. Low molecular weight iron in cerebral ischemic acidosis in vivo. Stroke 1998 29 : 487 92.
18. Levine SM. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res. 1997 760 : 298 303.
19. Babcock M, de Silva D, Oaks R et al. Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin. Science 1997 276 : 1709 12.
20. Rotig A, de Lonlay P, Chretien D et al. Aconitase and mitochondrial iron-sulfur protein deficiency in Friedreich ataxia. Nat. Genet. 1997 17 : 215 17.
21. Hurn PD, Koehler RC, Blizzard KK, Traystman RJ. Deferoxamine reduces early metabolic failure associated with severe cerebral ischemic acidosis in dogs. Stroke 1995 26 : 688 94.
22. Liachenko S, Tang P, Xu Y. Deferoxamine improves early postresuscitation reperfusion after prolonged cardiac arrest in rats. J. Cereb. Blood Flow Metab. 2003 23 : 574 81.
23. Nayini NR, White BC, Aust SD et al. Post resuscitation iron delocalization and malondialdehyde production in the brain following prolonged cardiac arrest. J. Free Radic. Biol. Med. 1985 1 : 111 16.
24. Girotti AW, Thomas JP, Jordan JE. Inhibitory effect of zinc (II) on free radical lipid peroxidation in erythrocyte membranes. J. Free Radic. Biol. Med. 1985 1 : 395 401.
25. Gagnon ZE, Patel A. Induction of metallothionein in chick embryos as a mechanism of tolerance to platinum group metal exposure. J. Environ. Sci. Health A Tox. Hazard Subst. Environ. Eng. 2007 15, 42 : 381 7.
26. Baird SK, Kurz T, Brunk UT. Metallothionein protects against oxidative stress-induced lysosomal destabilization. Biochem. J. 2006 394 : 275 83.
27. Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD. A model of focal ischemic stroke in the rat: Reproducible extensive cortical infarction. Stroke 1986 17 : 738 43.
28. Wang GX, Li GR, Wang YD, Yang TS, Ouyang YB. Characterization of neuronal cell death in normal and diabetic rats following exprimental focal cerebral ischemia. Life Sci. 2001 69 : 2801 10.
29. Sameto RP. Preparation of highly purified populations of neurons, astrocytes and oligodendrocytes. In : Conn PM (ed.). Methods in Neurosciences, Cell Culture, vol. 2. Academic Press, New York. 1990 119 33.
30. Liu R, Wang W, Song N, Chen Y, Li L. Diazoxide preconditioning alleviates apoptosis of hippocampal neurons induced by anoxia-reoxygenation in vitro through up-regulation of Bcl-2/Bax protein ratio. Acta Physiol. Sin. 2006 58 : 345 50.
31. Weinfeld A, Lundin P, Lundvall O. Significance for the diagnosis of iron overload of histochemical and chemical iron in the liver of control subjects. J. Clin. Pathol. 1968 21 : 35 40.
32. Uchiyama M, Mihara M. Determination of malondialdehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 1978 86 : 271 8.
33. Lowery OH, Rosenbrough NJ, Randall RJ. Protein measurement with Folin phenol reagent. J. Biol. Chem. 1995 195 : 256 75.
34. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 2001 : 21 : 2 14.
35. Choi BH. Oxygen, antioxidants and brain dysfunction. Yonsei Med. J. 1993 34 : 1 10.
36. Danielisova V, Gottlieb M, Burda J. Iron deposition after transient forebrain ischemia in rat brain. Neurochem. Res. 2002 27 : 37 42.
37. Kruman I, Bruce-Keller AJ, Bredesen D, Waeg G, Mattson MP. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 1997 17 : 5089 100.
38. Mattson MP, Culmsee C, Yu ZF. Apoptotic and antiapoptotic mechanisms in stroke. Cell Tissue Res. 2000 301 : 173 87.
39. 2 by iron salts. Proc. R. Soc. Lond. Ser 1934 147 : 332 51.
40. Ebadi M, Bashir RM, Heidrick FML et al. Neurotrophins and their receptors in nerve injury and repair. Neurochem. Int. 1997 30 : 347 74.
41. Trendelenburg G, Prass K, Priller J et al. Serial analysis of gene expression identifies metallothionein-II as major neuroprotective gene in mouse focal cerebral ischemia. J. Neurosci. 2002 22 : 5879 88.
42. Chen WY, John JA, Lin CH, Chang CY. Expression pattern of metallothionein, MTF-1 nuclear translocation, and its DNA-binding activity in zebrafish (Danio rerio) induced by zinc and cadmium. Environ. Toxicol. Chem. 2007 26 : 110 17.
43. Dalton T, Fu K, Plamiter RD, Andrews GK. Transgenic mice that overexpress metallothionein-I resist zinc deficiency. J. Nutr. 1996 126 : 825 33.
44. Cousins RJ, Lee-Ambrose LM. Nuclear zinc uptake and interaction and metallothionein gene expression are influenced by dietary zinc in rats. J. Nutr. 1992 122 : 56 64.
45. Doz F, Roosen N, Rosenblum ML. Metallothionein and anticancer agents: The role metallothionein in cancer chemotherapy. J. Neurooncol. 1993 17 : 123 9.
46. Furuta S, Suzuki M, Toyama S, Miwa M, Sano H. Tissue distribution of polaprezinc in rats determined by the double tracer method. J. Pharm. Biomed. Anal. 1999 19 : 453 61.
47. Carbonell T, Rama R. Iron, oxidative stress and early neurological deterioration in ischemic stroke. Curr. Med. Chem. 2007 14 : 857 74.
48. Gibbs PNB, Gore MG, Jordan PM. Investigation of the effect of metal ions on the reactivity of thiol groups in humans: Aminolevulinate dehydratase. Biochem. J. 1985 225 : 573 80.
49. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol. 1990 186 : 1 85.
50. Selim MH, Ratan RR. The role of iron neurotoxicity in ischemic stroke. Ageing Res. Rev. 2004 3 : 345 53.
51. Neal JW, Singhrao SK, Jasani B, Newman GR. Immunocytochemically detectable metallothionein is expressed by astrocytes in the ischaemic human brain. Neuropathol. Appl. Neurobiol. 1996 22 : 243 7.